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Andrographolide is a major bioactive secondary plant metabolite isolated Andrographis paniculata
(Burm. F.)Wall. Ex.Nees. (穿心蓮 chuanxın lian), awell-knowntraditionallyusedmedicinal herb. The aimof
the study was to pharmacologically evaluate the beneﬁcial effect of andrographolide on stress-induced
thermoregulatory and other physiological responses in mice. A stress-induced hyperthermia test was
conducted in mice. The test agents were orally administered once daily for 11 consecutive days, and
treatment effects on body weight changes, basal rectal temperature, and foot-shock-triggered hyperther-
mic responseswere quantiﬁedonDay1,Day5,Day7, andDay10of the experiments. Pentobarbital-induced
hypnosis was quantiﬁed on the 11th day of treatment. Observations made during a pilot dose ﬁnding
experiment revealed that, like A. paniculata extracts, pure andrographolide also possess adaptogenic
properties. Observeddose-dependent efﬁcacies of 3mg/kg/d,10mg/kg/d, and30mg/kg/d andrographolide
in the pilot experimentwere reconﬁrmedbyconducting two further analogous experiments using separate
groups of either male or female mice. In these conﬁrmatory experiments, efﬁcacies of andrographolide
were comparedwith thatof 5mg/kg/d oraldosesof the standardanxiolyticdiazepam. Signiﬁcantly reduced
body weights and elevated core temperatures of the three vehicle-treated control groups observed on the
5th day and subsequent observational days were completely absent even in the groups treated with the
lowest andrographolide dose (3 mg/kg/d) or diazepam (5 mg/kg/d). Benzodiazepine-like potentiation of
pentobarbital hypnosis was observed in andrographolide-treated animals. These observations reveal that
andrographolide is functionally a diazepam-like desensitizer of biological mechanisms, and processes
involved in stress trigger thermoregulatory and other physiological responses.
Copyright © 2015, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. All rights reserved.1. Introduction
Andrographis paniculata (Burm. F.) Wall. Ex. Nees. (穿心蓮 chuan
xın lian) is a herbaceous plant of the Acanthaceae family, often
cultivated in India, China, and other countries for medicinal pur-
poses. Due to its extremely bitter taste, it is often referred to as the
“the king of bitters,” and is used as a bitter tonic in Ayurvedic and
other traditionally known health care systems of India and manyarch Laboratory, Department
(Banaras Hindu University),
.
for Food and Biomolecules,
tories, Dr Willmar Schwabe
molecules, National Taiwan Univeother Asian countries. In traditional Chinese medicine, Androgra-
phis paniculata (Burm. F.) Wall. Ex. Nees. (A. paniculata) is indicated
for conditions of “heat,” particularly in the lungs, throat, and uri-
nary tract, as well as for manifestations of “ﬁre poison” on the skin,
such as sores and carbuncles.1 During more recent decades, the
plant has attracted considerable attention of modern drug discov-
erers and herbal researchers, and several reports revealing diverse
therapeutic potentials of different types of A. paniculata extracts in
properly controlled clinical trials have also appeared.2e5 Androg-
rapholide, structurally a labdane diterpenoid (Fig. 1), is quantita-
tively the major bitter-tasting secondary metabolite of the plant,
and it is now often considered to be the major bioactive constituent
of the plant involved in its observed therapeutically interesting
bioactivities.6e8 Although a very broad spectrum of therapeutically
interesting pharmacological properties of A. paniculata extracts and
pure andrographolide have now been revealed, many questionsrsity. Production and hosting by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. HPLC ﬁngerprint and chemical structure of andrographolide. HPLC ¼ high-performance liquid chromatography.
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remain unanswered.9,10 Available information on their medicinal
chemistry and pharmacology suggest, though, that like various
other bioactive secondary plant metabolites, andrographolide is
also a pharmacologically pleiotropic or polyvalent agent, and that
most probably several biological targets and mechanisms are
involved in its modes of actions.
Apart from andrographolide, > 20 other structurally analogous
diterpenoids as well as > 10 ﬂavonoids have been isolated and
pharmacologically characterized from diverse types of A. paniculata
extracts currently commercialized for medicinal purposes.2 It has
been suggested that clinically observed beneﬁcial effects of such
extracts against upper respiratory tract infections could also be due
to their adaptogenic-like properties,11 and several modern scholars,
researchers, and practitioners of Ayurvedic and other traditionally
known systems of medicine consider A. paniculata to be another
adaptogenic herb.12e15 However, as yet little efforts have been
made to experimentally verify the possibility that andrographolide
can also be quantitatively the major adaptogenic secondary
metabolite of the plant. Pharmacologically, adaptogens are char-
acterized by their broad spectra of bioactivities in animal models
commonly used for identifying antistress, nootropic, immune
function modulating, and antioxidant properties of test agents, and
numerous better scrutinized adaptogenic herbs still continue to be
recommended by modern herbalists for prevention and cure of
mental health problems.16 Consequently, at present, diverse com-
binations of behavioral and other models usually used for discov-
ering and developing psychoactive drugs are now commonly used
for predicting or estimating their therapeutic potentials as adap-
togenic herbs and their bioactive constituents.17,18
During the course of our psychopharmacological studies with
traditionally known herbal remedies,19 a modiﬁed version of the
conventionally known stress-induced hyperthermia test for anxi-
olytics was identiﬁed as a convenient test for assessing pharma-
cologically interesting dose ranges and treatment regimen of
adaptogenic herbal extracts.20 This foot-shock stress-induced hy-
perthermia test is now regularly used in our laboratories forprimary pharmacological screening of commercialized extracts
from adaptogenic herbs, or for identifying their bioactive properties
and comparing their adaptogenic potentials with those of the
parent extracts. Observations made during our efforts to deﬁne
pharmacologically interesting doses and treatment regimen of a
medicinally used A. paniculata extract have revealed that its efﬁcacy
in this bioassay appears gradually after its repeated daily dose
only.21 This extract is highly rich in andrographolide (> 30% w/w),
and diverse other types of A. paniculata extracts rich in androgra-
pholide are used in India, China, and other Asian countries for
treatment of upper respiratory tract infections.11,22 Therefore, it was
of interest to test whether andrographolide could also be its
quantitatively major adaptogenic constituent involved in its clini-
cally observed symptomatic relief in patients suffering from the
common cold. Results of these very ﬁrst sets of experiments con-
ducted to experimentally verify this possibility are described and
discussed in this article. Possible implications of these ﬁndings for
discovering drug leads from andrographolide and other structurally
or functionally analogous secondary plant metabolites are also
pointed out.
2. Materials and methods
2.1. Animals
Male and female Swiss albino mice (20 ± 5 g) were acquired
from the Central Animal House of the Institute of Medical Sciences,
Banaras Hindu University, Varanasi, India (Registration Number:
542/AB/CPCSEA). Prior approval was granted by the Central Animal
Ethical Committee of the Banaras Hindu University, Varanasi, India
for the study protocol (Dean/11-12/CAEC/325, dated November 30,
2011), and the “Principles of laboratory care” (NIH publication
number 85-23, revised during 1985) guidelines were always fol-
lowed. The animals were housed in groups of six in polypropylene
cages, and maintained at an ambient temperature of 25 ± 1C and
45e55% relative humidity, with a 12:12 hours of light/dark cycle.
They were provided with commercial food pellets and tap water ad
A.K. Thakur et al. / Journal of Traditional and Complementary Medicine 5 (2015) 42e5044libitum, and acclimatized to laboratory conditions for at least 1
week prior to using them in the experiment. All test parameters
were assessed between 9.00 hours and 14.00 hours.2.2. Drugs and chemicals
Analytically pure andrographolide [99.0% by high-performance
liquid chromatography (HPLC); Fig. 1] isolated from A. paniculata
was generously supplied by R&D Center, Natural Remedies Pvt. Ltd.,
Bangalore, India. Details of the extraction procedure and analytical
method used for standardization of the A. paniculata extract used in
our earlier studies have been reported elsewhere.23 Brieﬂy,
extraction of coarsely ground A. paniculata leaves was performed
with methanol for 3 hours, in a stainlessesteel-jacketed extractor
ﬁtted with a reﬂux condenser. The liquid extract was removed, and
the remaining raw material was re-extracted two more times with
methanol in a similar manner. The resulting extracts were com-
bined, concentrated, and dried under vacuum (at < 55C). The yield
of the dried extract was 6% (w/w). Analytically, the extract was
standardized to contained andrographolide (> 30.0%, w/w), iso-
andrographolide (> 0.3%, w/w), neoandrographolide (> 1.0%, w/w),
andrograpanin (> 0.3%, w/w), and 14-deoxy-11,12 didehydroan-
drographolide (< 5.0%, w/w). The extract was subjected to liquid-
eliquid partitioning between ethyl acetate and water. The ethyl
acetate layer was repeatedly chromatographed over silica gel using
a combination of hexane:ethyl acetate and chloroform:methanol.
Purity of the isolated compounds was determined by HPLC. Diaz-
epam (Cipla, Ahmadabad, India), Tween 80 (Sisco Research Lab.,
Mumbai, India), Agar (Central Drug House, Delhi, India), and other
chemicals and reagents used were obtained from commercial
sources.2.3. Animal grouping and drug administration
In the pilot experiment, equal numbers of male and female
animals were allotted to each treatment group, whereupon the
vehicle-treated control group consisted of 12, and the drug-treated
ones consisted of six animals each. The six groups used in this
experiment were as follows: Group I (negative control)dtreated
with vehicle; Group IIdtreated with andrographolide (3 mg/kg,
p.o.); Group IIIdtreated with andrographolide (10 mg/kg, p.o.);
Group IVdtreated with andrographolide (30 mg/kg, p.o.); Group
Vdtreated with andrographolide (100 mg/kg, p.o.), and Group
VIdtreated with andrographolide (300 mg/kg, p.o.). Based on the
observation made in the pilot experiment, two further conﬁrma-
tory experiments using either male or female mice (6 animals per
group) were conducted. In each of these two experiments, the
animals were allotted to the following experimental groups: Group
I (negative control)dtreated with vehicle; Group IIdtreated with
andrographolide (3 mg/kg, p.o.), Group IIIdtreated with androg-
rapholide (10mg/kg, p.o.), Group IVdtreatedwith andrographolide
(30 mg/kg, p.o.), and Group V (positive control)dtreated with
diazepam (5 mg/kg, p.o.). For oral administrations, the test agents
were macerated with 2% Tween 80 and then suspended in 0.2%
aqueous agar, and were administered once daily for 11 consecutive
days. The control groups were treated with this vehicle combina-
tion only. All procedures used have been well standardized and
regularly used in our laboratory for evaluating adaptogenic po-
tentials of herbs and other test agents. Selection of the androgra-
pholide doses for the pilot dose-ﬁnding experiment and the test
procedure used were based on our earlier observation with a
therapeutically used A. paniculata extract rich in andrographolide
(> 30% w/w).21,242.4. Stress-induced hyperthermia and pentobarbital-induced
hypnosis
Treatments on Day 1, Day 5, Day 7, and Day 10 were given after
measuring their basal core temperatures with a calibrated rectal
thermometer (Digital Thermometer; Dr. Gene, New Delhi, India).
Tests were always conducted 60minutes after the day’s treatments,
and observations were made in a blinded manner. All animals were
subjected to a foot-shock stress-triggered hyperthermia test on Day
1, Day 5, Day 7, and Day 10 of the experiment. For such purposes,
they were individually placed in a black box (24  29  40 cm3)
with a grid ﬂoor for 1 minute. During this period, the animals
received ﬁve consecutive foot-shocks (2 mA, 50 Hz of 2-millisecond
duration each) at 10-second intervals from the grid ﬂoor, after
which they were immediately placed back to their home cages.
Rectal temperatures of the animals were then measured again after
10 minutes of the foot-shock exposure by a blinded observer.25
Calculated difference between the ﬁrst and the last temperature
measurements of an animal on a test day was used to quantify
stress-induced hyperthermia.
On the 11th day, treatments were administered without prior
rectal temperature measurements and 60 minutes prior to pento-
barbital (40 mg/kg, i.p.) challenge. Rectal temperatures were
measured on this day immediately prior to the pentobarbital
challenge. The time necessary for pentobarbital-induced sleep in-
duction (loss of righting reﬂex) and duration of sleepwere recorded
by a blinded observer.26
2.5. Statistical analysis
Mean ± standard error of mean was calculated from the values
observed in each experimental group. Unless stated otherwise,
statistical analysis was performed by one-way analysis of variance
followed by StudenteNewmaneKeuls multiple comparison test.
GraphPad Prism-5 software (GraphPad Software Inc., San Diego, CA,
USA) was used for statistical analysis and calculation of ED50 value.
A p value of < 0.05 for differences was considered to be statistically
signiﬁcant.
3. Results
Body weights and rectal temperatures of all age-matched ani-
mals used in the three described experiments on the initial experi-
mental days were within physiological ranges. During the course of
the experiments, the mean body weights of all the three vehicle-
treated control groups decreased consistently, and their mean
basal core temperatures recordedonDay5,Day7,Day10, andDay11
of the experiments were signiﬁcantly (p < 0.05) higher than those
observed on the initial experimental days (Fig. 2A and B). Such ele-
vations of basal core temperature of the control groups in the two
experiments, conducted onlywithmale or female animals, occurred
gradually during the course of the experiments, and remained
constant on the 10th experimental day and 11th experimental day
(Fig. 2B andC). Thiswas not the case for the control group in the pilot
experiment,where equal numbers ofmale and female animalswere
used in all experimental groups. In this experiment, the mean basal
rectal temperatures of the control group recorded on the 5th day
were almost equal in magnitude to those recorded on subsequent
observational days of the experiment (Fig. 2B). The magnitudes of
this elevation in basal core temperatures due to daily handling and
transient foot-shocks observed on the 10th day and 11th day in the
control groups of all the three experiments were almost equal, and
such was also the case for the magnitude of foot-shock stress-trig-
gered transient hyperthermia in all the three vehicle-treated control
groups (Fig. 2C). The mean time of onset of sleep and durations of
Fig. 2. Mean (± SEM) of (A) body weights, (B) basal rectal temperatures, (C) foot-shock stress-induced hyperthermic responses, and (D) sleep onset periods and durations of sleep
induced by pentobarbital in the vehicle-treated control groups used in the three reported experiments. The number of control animals used in the pilot experiment was 12, and that
in each of the two conﬁrmatory experiments was 6. No statistically signiﬁcant differences (2-tailed t test) were detected between the values observed in separate groups of male and
female animals used in the conﬁrmatory experiments. SEM ¼ standard error of mean.
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experiments observed in all the three control groups were also
almost equal in magnitudes (Fig. 2D).
Observed effects of daily oral doses of andrographolide and the
number of treatment days on the four parameters quantiﬁed in the
pilot experiment are summarized in Fig. 3. These results revealed
that even a very high single oral dose of andrographolide (300 mg/
kg) did not alter the basal rectal temperature of the animals and
had no statistically signiﬁcant effects on their acute responses to
foot-shock-triggered hyperthermia. However, signiﬁcant (p < 0.05)
inhibitory effects of even the lowest tested andrographolide doses
(3 mg/kg/d) on both these quantiﬁed parameters were apparent on
the 5th day and on subsequent days of the experiment. Body weight
losses of the animals of the 3 mg/kg/d andrographolide-treated
group on the 5th day and on subsequent experimental days were
also less severe than those observed in the vehicle-treated control
group on these days. The mean body weights of the animals of all
other andrographolide-treated groups on 5th day were signiﬁcantly
(p < 0.05) higher than those recorded for the groups on Day 1 of the
experiment and remained almost constant during the subsequent
experimental days (Fig. 3A). The mean basal core temperatures in
the groups treated with 3 mg/kg/d, 10 mg/kg/d, and 30 mg/kg/
d andrographolide on the 1st experimental day and 5th experi-
mental day were almost identical to each other. Numerically, the
mean basal core temperatures in the 100 mg/kg/d and 300 mg/kg/
d andrographolide-treated groups on Day 5 were somewhat higherthan (but not statistically signiﬁcantly different from) those recor-
ded for the groups on Day 1. The mean basal core temperatures in
all andrographolide-treated groups on the 7th day,10th day, and 11th
days remained almost constant, and were always signiﬁcantly
(p < 0.05) lower than those of the control group on these days
(Fig. 3B).
Statistically signiﬁcant (p < 0.05) dose and duration of
treatment-dependent antagonistic effects of andrographolide on
foot-shock-triggered hyperthermia were also observed on the 5th
day, 7th day, and 10th day of the pilot experiment (Fig. 3C). The
efﬁcacy of andrographolide observed on the 5th day was much
lower than those observed on the 7th day and 10th day. Hereupon,
efﬁcacies of the highest two tested doses were almost identical.
However, even after administering the highest andrographolide
dose tested (300 mg/kg/d), the foot-shock stress-triggered hyper-
thermic responses were only partially antagonized on both of these
days. The estimated ED50 values of andrographolide in this test on
the 7th day and 10th day of the experiment were 10.88 mg/kg/d and
10.35 mg/kg/d, respectively. Dose-dependent potentiating effects
of 10 daily andrographolide treatments on pentobarbital-induced
sedation and hypnosis were observed on the 11th day of the
experiment. Log doseeresponse curves for these effects of
andrographolide are shown in Fig. 3D. The estimated ED50 vales of
andrographolide for prolongation of onset time and duration of
sleep induced by pentobarbital were 13.76 mg/kg/d and 12.36 mg/
kg/d, respectively.
Fig. 3. Effects of once-daily oral doses of andrographolide on the parameters quantiﬁed in the pilot experiment for 10 consecutive days observed. (A) Mean body weights (B) and
basal core temperature were quantiﬁed on different days of the experiment. Andrographolide doseeresponse curves (C) in the foot-shock stress-induced hyperthermia test
conducted on Day 1, Day 5, Day 7, and 10 of the experiment and (D) in the pentobarbital sleep test conducted on Day 11 of the test are shown in this ﬁgure. Observed statistically
signiﬁcant (p < 0.05) mean values of andrographolide-treated groups against the mean values of the control group on the same day are marked with *, and such differences
(p < 0.05) between the mean values of a group on Day 1 and on subsequent days of the experiment are marked with the symbol ¥. Percent response values used in the dos-
eeresponse curves were calculated by considering the responses of the control group on the day of the experiment as 100%.
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verify the observations made in the pilot experiment, but also to
test whether the observed efﬁcacy of andrographolide could be
different in male and female animals. Results of these two experi-
ments are summarized in Figs. 4e6. Although somewhat lower
mean body weights, and higher basal rectal temperatures and
calculated values of foot-shock-triggered hyperthermia were
observed in the vehicle-treated female control group on the 1st day
and on subsequent observational days of the experiments, these
mean values were not statistically signiﬁcantly different from the
corresponding values of the vehicle-treated male control group
(Fig. 2), and no statistically signiﬁcant differences between the ef-
fects of daily handling and transient foot-shocks on male and fe-
male mice were observed during the entire experimental period.
Such were also the cases for all dose-dependent effects of
andrographolide or those of the tested dose (5 mg/kg/d) of the
anxiolytic diazepam used as a reference standard in these
experiments.
4. Discussion
Observations reported in this communicationweremade during
our efforts to pharmacologically validate the described bioassay for
identifying bioactive properties of adaptogenic herbs (Fig. 7). They
revealed that not only physiological effects of daily handling andintermittent foot-shocks on body weights and thermoregulatory
mechanisms of male and female adult mice are indistinguishable
under the experimental conditions used in our laboratories, but
also the observed effects of andrographolide on the quantiﬁed
parameters are qualitatively analogous to those observed for the
medicinally used A. paniculata extract in our laboratories earlier.21
All quantiﬁed effects of andrographolide were qualitatively analo-
gous to those observed after daily oral administration of the 5 mg/
kg dose of diazepam.
Diazepam is an anxiolytic agent often used as a reference drug
for pharmacological validation of animal models (including diverse
versions of stress-induced hyperthermia tests) for the anxiety state
of animals or for detecting acute dose anxiolytic-like activities of
test agents.20 However, in both the conﬁrmatory experiments re-
ported in this communication, no acute dose effects of the anxio-
lytic drug were observed. These observations could indicate that
physiological processes andmechanisms involved in the foot-shock
stress-triggered hyperthermia are not identical to those involved in
transient hyperthermia triggered by milder physiological stimuli
commonly used in other versions of stress-induced hyperthermia
tests for anxiolytics, or for identifying gamma-aminobutyric acid
(GABA) receptor function modulating agents. A literature survey
revealed, though, that most studies on the effects of diazepam in
diverse versions of stress-induced hyperthermia test were con-
ducted after intraperitoneal administration of its acute doses only.
Fig. 4. Effects of intermittent foot-shocks and daily handling on (A and B) body weights and (C and D) basal rectal temperatures of male and female mice treated with vehicle, or
andrographolide, or diazepam. * p < 0.05 versus control values on the same day. ¥ p < 0.05 versus Day 1 values of the same group.
Fig. 5. Effects of daily handling on foot-shock stress-triggered hyperthermia on Day 1, Day 5, Day 7, and Day 10 in (A) male and (B) female mice treated with vehicle, or
andrographolide, or diazepam. * p < 0.05 versus control values on the same day. ¥ p < 0.05 versus Day 1 values of the same group.
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Fig. 6. Effects of andrographolide or diazepam treatments on pentobarbital-induced
sleep parameters quantiﬁed on Day 11 of treatments in (A) male and (B) female
mice. * p < 0.05 versus control.
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diazepam < 6 mg/kg are ineffective in one of the most commonly
used versions of the stress-induced hyperthermia test using mice
as experimental animals,27 and that, at lower doses, it also affords
protection against diverse stress-triggered pathologies. Because we
were interested in comparing the effects of repeated daily doses of
andrographolide on thermoregulatory processes, and from our
earlier observations we had also known that 5 mg/kg daily oral
doses of diazepam is effective in desensitizing mild stress-triggered
slight elevation of rectal temperature, this dose of the anxiolytic
was considered appropriate for our purpose.
It is well known that, apart from its anxiolytic activity, diazepam
also possesses diverse other stress response modulating effects28,29
and that, depending on its dose administered for protracted
treatments, tolerance liability of diazepam varies considerably.30
Our observations clearly revealed that all physiological responses
quantiﬁed in the bioassay used are antagonized by diazepam after
its 5 mg/kg repeated daily oral doses only, and that its activity
proﬁle observed after this dose of the anxiolytic administered for >
5 days is almost identical to that observed after 10 mg/kg/d oral
treatment regimen of pure andrographolide. Therefore, it seems
reasonable to assume that the biological processes and mecha-
nisms involved in the observed effects of the two agents must have
some similarities. However, since even after the administration of
very high single oral doses of andrographolide, it did not have any
effects on stress-induced hyperthermia, its mode and site of action
cannot be identical to those of benzodiazepines.
In any case, it remains certain that qualitatively the activity
proﬁle of an A. paniculata extract observed earlier in our labora-
tories in the bioassay used is identical to that of pureandrographolide observed in the experiments described in this
communication.21 However, the ED50 values of pure androgra-
pholide estimated in this study were always signiﬁcantly lower
than those calculated from the doseeresponse curves of androg-
rapholide present in the tested extract administered and using the
same bioassay procedure.21 Therefore, it appears that some other
bioactive constituents present in the tested extract modulate the
stress response desensitizing effects of andrographolide observed
in the bioassay.
The possibility that bioactive agents could have adaptogenic
properties evolved from pharmacological observations made
initially in Russia with a structurally well-deﬁned molecule during
the 1940s.31 Since then, the concept that adaptogenic properties of
herbal remedies are involved in their medicinal beneﬁts has been
well accepted by almost all scholars, researchers, and practitioners
of integrative medicine who are also well trained in modern
medical sciences.16 By deﬁnition, adaptogens are nontoxic, or well-
tolerated, bioactive substances capable of counteracting or pre-
venting homeostatic disturbances triggered by metabolic, envi-
ronmental, and mental stresses. The facts that andrographolide is a
nontoxic substance is evident from a recently reported toxicolog-
ical study,32 and is reconﬁrmed by the observations made in the
pilot experiment described in this communication. This experiment
was conducted to estimate the pharmacologically interesting dose
and treatment regimen of andrographolide using its daily oral
doses of up to 300 mg/kg/d. Even after administering its highest
tested dose, no apparent behavioral and other apparent toxicities of
andrographolide were observed in this experiment during the 11
observational days. By contrast, even the lowest andrographolide
dose tested (3 mg/kg/d) completely prevented the daily handling-
and intermittent foot-shock-triggered body weight losses, and the
slight elevation of core body temperatures within physiological
ranges observed in control animals. Moreover, dose- and treatment
regimen-dependent partial protection against transient foot-shock-
triggered hyperthermia, with ED50 values around 10 mg/kg/d, was
observed in the pilot as well as in both the conﬁrmatory experi-
ments. Because the dose and duration of treatment dependence of
these observed effects of andrographolide were not identical, it
seems reasonable to assume that different physiological thermo-
regulatory mechanisms and biological processes are involved in its
diazepam-like beneﬁcial effects observed only after their fairly low
daily oral doses.
Numerous behavioral alterations induced by daily handling of
experimental animals have long since been known to experimental
pharmacologists,33 and it is also well recognized that almost all
handling procedures necessary for in vivo bioassays drastically alter
their metabolic status, basal core temperature, and numerous other
physiological parameters.34 However, until now, daily handling
stress-induced homeostatic and behavioral alterations have seldom
been used for identifying adaptogenic or antistress potentials of
test agents. Stress-induced hyperthermia paradigm is now regu-
larly used by numerous drug discoverers for identifying acute dose
effects of structurally and functionally novel psychoactive drugs
potentially useful for treatment of exaggerated anticipatory anxi-
ety,35,36 or for overall estimation of stress responses in experi-
mental and other animals.37 Because clear dose-dependent
diazepam-like effects of andrographolide against foot-shock
stress-triggered hyperthermia were apparent after its repeated
daily doses, it seems reasonable to assume that neurotransmitter
mechanisms modulated by such treatments are analogous to those
of conventionally known benzodiazepine-like anxiolytics. The ob-
servations that daily treatments with andrographolide also
potentiate pentobarbital-induced sedation and hypnosis, and that
its doseeresponse curves for such effects are almost identical to
those observed on the 7th observational day and 10th observational
Fig. 7. Graphical summary.
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this possibility. As both benzodiazepines and barbiturates are well-
known modulators of central GABAA receptors, modulation of
functions of the GABAergic system may also be involved in the
observed effects of andrographolide after its repeated daily doses.
Among diverse therapeutic potentials of andrographolide
identiﬁed to date, those dealing with its anti-inﬂammatory and
anticancer activities have attracted the most attention of modern
drug discovers.2e8,22 Since available information on its pharmaco-
kinetics and metabolism has revealed its low oral bioavailability,38
efforts are now being made in several laboratories to identify
structurally novel and orally better bioavailable andrographolide
derivatives and their analogs as potential drug leads.39 All such
drug discovery approaches are based on the conviction that blood
levels of andrographolide dictate its pharmacological efﬁcacy. This
may not necessarily be the case as clearly indicated not only by the
observation reported in this communication, but also by our earlier
report on nervous system function modulating effects of an
A. paniculata extract rich in andrographolide (>30% w/w).21
Medicinal values of andrographolide-enriched A. paniculata
extracts for treatment of gastrointestinal and hepatic disorders
have long since been well recognized by Ayurvedic and other
traditionally known medical practitioners. Efﬁcacy of one such
extract for obtaining symptomatic relief in patients with inﬂam-
matory bowel diseases has also been demonstrated in a recently
reported clinical trial.40 Moreover, therapeutic beneﬁts of such
extracts against other diverse chronic inﬂammatory disorders, now
commonly grouped under the heading “central sensitivity syn-
drome,” have repeatedly been demonstrated by several other
properly controlled clinical trials.10,41 It is also nowwell recognized
that the gut microbiota ecology and the gut brain axis play
important roles in altering central sensitivity of almost all inﬂam-
matory diseases,42,43 and that the gut microbiota ecology of labo-
ratory mice is altered by daily handling of them for experimental
purposes.44 Since antimicrobial, antifungal, and antiparasitic ac-
tivities of andrographolide and other A. paniculata extract compo-
nents are known,45 it could also be that the reported therapeutic
beneﬁts of the extracts and the observed effects of andrographolide
against stress-induced hyperthermia reported in this communica-
tion are possibly due to their modulating effects on the gut
microbiota ecology. Efforts to experimentally verify this possibility
are now being made in our laboratories.
Maximal suppressive effects of andrographolide against hyper-
thermia induced by daily handling was observed after its ﬁve daily
doses of 3 mg/kg, and its daily dose of 3 mg/kg for a period of 30
days has been reported to be its maximally effective dose in threedifferent gastric ulcer models.46 However, antihyperglycemic and
antidiabetic activities of pure andrographolide have also been
observed after its oral doses as low as 1.5 mg/kg.47,48 Our obser-
vations, together with others reported to date on pharmacological
activity proﬁle of andrographolide after its repeated oral doses,
strongly suggest that it is an orally active antihyperglycemic agent
with gastric ulcer protective and antistress activity, and that its
structural modulations are not essential prerequisites for obtaining
such therapeutic beneﬁts from this naturally abundant phyto-
chemical. Therefore, efforts to experimentally verify the possibility
that andrographolide itself can also be useful for the prevention
and cure of metabolic disorders triggered by or associated with
environmental and metabolic stress seem to be an urgent thera-
peutic necessity. During such efforts, due attention has to be paid to
the adaptogenic effects of andrographolide induced after its
repeated daily doses.
5. Conclusion
Andrographolide is quantitatively the major adaptogenic sec-
ondary metabolite of A. paniculata. Downregulation of the func-
tions of the benzodiazepine site of GABA-A receptors involved in
stress-triggered physiological responses by repeated daily intake
of andrographolide is most probably involved in its adaptogenic
activity.
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